Management of Conflicts of Interest. 21.1 The Company acknowledges that it is aware of UBC’s Conflict of Interest Policy SC3, Inventions and Discoveries Policy LR11 and Research Policy LR2 (h▇▇▇▇://▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇.▇▇/▇▇▇▇▇-of-govemors-policies-procedures-rules-and-guideline s/policies/ ), and that UBC may amend these policies or introduce new policies from time to time. 21.2 Subject to Article 21.3 the Company and UBC agree, that: (a) the facilities and research programs of the Company will be conducted independently of all UBC facilities, faculty, students or staff, and in particular, independently of and from the Investigator(s) and the laboratory facilities made available to the Investigator(s) by reason of the Investigator(s)’ employment at UBC; (b) no students, post-doctoral fellows or other UBC staff will participate or be involved in the Company’s research, projects or utilize its facilities; and (c) any disclosures of inventions made by the Investigator(s) to the Company will be immediately forwarded by the Company to UBC. 21.3 The Company and UBC may, from time to time, enter into written agreements to permit activities which would otherwise be prohibited by Article 21.2.
Appears in 2 contracts
Sources: Start Up License Agreement (Asep Medical Holdings Inc.), Start Up License Agreement (Asep Medical Holdings Inc.)